➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: June 14, 2021

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for IMPLANON

Email this page to a colleague

« Back to Dashboard

Bulk Pharmaceutical API Sources for IMPLANON

Vendor Vendor Homepage Vendor Sku API Url
NovoSeek   Get Started Free 6917715   Get Started Free
ZINC   Get Started Free ZINC11680067   Get Started Free
MolPort   Get Started Free MolPort-003-847-336   Get Started Free
ABI Chem   Get Started Free AC1OCEK1   Get Started Free
ChemMol   Get Started Free 49425235   Get Started Free
Chembase.cn   Get Started Free 168816   Get Started Free
Shenzhen Nexconn Pharmatechs. Ltd   Get Started Free Etonogestrel   Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.